Publications Toxicology

Selinski S, Bürger H, Blaszkewicz M, Otto T, Volkert F, Moormann O, Niedner H, Hengstler JG, Golka K:

Occupational risk factors for relapse-free survival in bladder cancer patients. J Toxicol Environ Health 79A: 1136-1143 (2016)

Föllmann W, Ali N, Blaszkewicz M, Degen GH:

Biomonitoring of mycotoxins in urine: pilot study in mill workers. J Toxicol Environ Health 79A:1015-1025 (2016)

Hellwig B, Madjar K, Edlund K, Marchan R, Cadenas C, Heimes AS, Almstedt K, Lebrecht A, Sicking I, Battista MJ, Micke P, Schmidt M, Hengstler JG, Rahnenführer J:

Epsin family member 3 and ribosome-related genes are associated with late metastasis in estrogen receptor-positive breast cancer and long-term survival in non-small cell lung cancer using a genome-wide identification and validation strategy. PLoS One 11(12): e0167585 (2016)

Krech S, Selinski S, Bürger H, Hengstler JG, Jedrusik P, Hodzic J, Knopf H-J:

Occupational risk factors for prostate cancer in an area of former coal, iron and steel industries in Germany. Part 2: Results from a study performed in the 1990s. J Toxicol Environ Health 79A: 1130-1135 (2016)

Dickhut S, Urfer W, Reich S, Bandel T, Bremicker K-D, Neugebauer W, Sökeland J, Bolt HM, Golka K:

Occupational risk factors for prostate cancer in an area of former coal, iron, and steel industries in Germany. Part 1: Results from a study performed in the 1980s. J Toxicol Environ Health 79A: 1125-1129 (2016)

Pacharra M, Kleinbeck S, Schäper M, Juran SA, Hey K, Blaszkewicz M, Lehmann M-L, Golka K, van Thriel C:

Interindividual differences in chemosensory perception: toward a better understanding of perceptual ratings during chemical exposures. J Toxicol Environ Health 79A: 1026-1040 (2016)

Pink M, Ratsch BA, Mardahl M, Durek P, Polansky JK, Karl M, Baumgrass R, Wallner S, Cadenas C, Gianmoena K, Floess S, Chen W, Nordstroem K, Tierling S, Olek S, Walter J, Hamann A, Syrbe U:

Imprinting of skin/inflammation homing in CD4+ T cells is controlled by DNA methylation within the fucosyltransferase 7 gene. J Immunol 197: 3406-3414 (2016)

Arbo MD, Melega S, Stöber R, Schug M, Rempel E, Rahnenführer J, Godoy P, Reif R, Cadenas C, de Lourdes Bastos M, Carmo H, Hengstler JG:

Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis. Arch Toxicol 90: 3045-3060 (2016)

Chaudhari U, Nemade H, Gaspar JA, Hescheler J, Hengstler JG, Sachinidis A:

MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol 90: 3087-3098 (2016)

Ecke TH, Huang-Tiel H-J, Golka K, Selinski S, Geis BC, Koswig S, Bathe K, Hallmann S, Gerullis H:

Prostate specific antigen (PSA) as predicting marker for clinical outcome and evaluation of early toxicity rate after high-dose rate brachytherapy (HDR-BT) in combination with additional external beam radiation therapy (EBRT) for high risk prostate cancer. Int J Mol Sci 17: 1879 (2016) (10 pp)